OncoCyte Corp (OCX)

4.85
AMEX : Health Care
Prev Close 4.70
Day Low/High 4.70 / 4.85
52 Wk Low/High 2.95 / 7.95
Avg Volume 20.60K
Exchange AMEX
Shares Outstanding 28.71M
Market Cap 134.93M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Don M. Bailey Appointed To OncoCyte Corporation's Board Of Directors

Don M. Bailey Appointed To OncoCyte Corporation's Board Of Directors

Experienced Senior Executive with Track Record of Consistently and Rapidly Building Shareholder Value at Several Companies Makes Equity Investment in OncoCyte

OncoCyte Corporation Announces The Closing Of Two Private Placement Transactions Generating Gross Proceeds Of $10.55 Million

OncoCyte Corporation Announces The Closing Of Two Private Placement Transactions Generating Gross Proceeds Of $10.55 Million

Net Proceeds to be Used to Continue R&D of Non-Invasive Cancer Diagnostics Tests and CLIA Compliant Laboratory Build-Out

OncoCyte Reports Second Quarter 2016 Financial Results

OncoCyte Reports Second Quarter 2016 Financial Results

Conference Call to Discuss the Results at 5:00 p.m. ET

OncoCyte Commences Analytical Verification Study For Lung Cancer Diagnostic Test

OncoCyte Commences Analytical Verification Study For Lung Cancer Diagnostic Test

Expects to Complete the Studies Later this Year and Continues to Project Commercial Launch in the First Half of 2017

BioTime, Inc. Reports Second Quarter Results And Recent Corporate Accomplishments

BioTime, Inc. Reports Second Quarter Results And Recent Corporate Accomplishments

BioTime, Inc. (NYSE MKT:BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today reported financial results for the second quarter ended June 30, 2016 and provided a...

WireCo Announces Investment From Onex

WireCo Announces Investment From Onex

OncoCyte To Release Bladder Cancer Data At The 2016 American Society Of Clinical Oncology Annual Meeting

OncoCyte To Release Bladder Cancer Data At The 2016 American Society Of Clinical Oncology Annual Meeting

Positive New Data to be Featured in a Poster Discussion

OncoCyte Reports First Quarter 2016 Financial Results

OncoCyte Reports First Quarter 2016 Financial Results

Conference Call to Discuss the Results at 5 p.m. ET